Literature DB >> 3968441

A micro enzyme-linked immunosorbent assay for insulin antibodies in serum.

T Wilkin, S Nicholson, C Casey.   

Abstract

A solid-phase micro enzyme-linked immunosorbent assay for the measurement of insulin antibodies in serum is described and its performance compared with that of an established radiobinding assay. Interassay precision in the ELISA was 10% or less at widely spaced points on the dilution curves for human, porcine and bovine insulins. Specificity was demonstrated by substituting purified human gamma-globulin for the test serum and glucagon for the insulin. The influence on ELISA of endogenous insulin in the test serum was examined by measuring antibody binding before and after extraction of the insulin. The correlation between results from extracted and unextracted sera was 0.96 and the fit ideal: y = 1.00x + 0.38%. The correlation between the results of measuring insulin antibody in 256 diabetic sera by the 2 assays was r = 0.74, P less than 0.001 (human insulin) and r = 0.71, P less than 0.001 (porcine insulin). ELISA is cheap and simple to perform. We believe it may prove to be a practical alternative to radioassay in both the routine detection and investigative research of insulin antibodies.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3968441     DOI: 10.1016/0022-1759(85)90490-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  15 in total

1.  Insulin autoantibodies in non-obese diabetic (NOD) mice.

Authors:  C Michel; C Boitard; J F Bach
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

2.  Antigenicity of the carboxyl terminus of insulin: isolation of human insulin-specific monoclonal antibodies.

Authors:  I H Mirza; T J Wilkin
Journal:  Immunology       Date:  1988-09       Impact factor: 7.397

3.  Effect of buspirone: An anxiolytic drug on blood glucose in humans.

Authors:  S K Ojha; M Nandave; C Sharma
Journal:  Indian J Clin Biochem       Date:  2006-09

4.  Natural thymocytotoxic autoantibodies in non-obese diabetic (NOD) mice: characterization and fine specificity.

Authors:  A Lehuen; J Altman; J F Bach; C Carnaud
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

5.  Insulin autoantibodies in the pre-diabetic period: correlation with islet cell antibodies and development of diabetes.

Authors:  B M Dean; F Becker; J M McNally; A C Tarn; G Schwartz; E A Gale; G F Bottazzo
Journal:  Diabetologia       Date:  1986-05       Impact factor: 10.122

6.  Semi-quantitative assessment of anti-insulin total IgG and IgG sub-classes in insulin-immunized patients using a highly sensitive immunochemical micromethod.

Authors:  M Koch; C François-Gérard; F Sodoyez-Goffaux; J C Sodoyez
Journal:  Diabetologia       Date:  1986-10       Impact factor: 10.122

7.  Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study.

Authors:  C Betterle; F Presotto; B Pedini; L Moro; R S Slack; F Zanette; R Zanchetta
Journal:  Diabetologia       Date:  1987-05       Impact factor: 10.122

8.  Increased proinsulin levels as an early indicator of B-cell dysfunction in non-diabetic twins of type 1 (insulin-dependent) diabetic patients.

Authors:  D A Heaton; B A Millward; I P Gray; Y Tun; C N Hales; D A Pyke; R D Leslie
Journal:  Diabetologia       Date:  1988-03       Impact factor: 10.122

9.  Ontogeny of islet cell antibodies, insulin autoantibodies and insulitis in the non-obese diabetic mouse.

Authors:  S Reddy; N J Bibby; R B Elliott
Journal:  Diabetologia       Date:  1988-05       Impact factor: 10.122

10.  Counterregulatory hormonal responses to hypoglycaemia in type 1 (insulin-dependent) diabetes: evidence for diminished hypothalamic-pituitary hormonal secretion.

Authors:  B M Frier; B M Fisher; C E Gray; G H Beastall
Journal:  Diabetologia       Date:  1988-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.